Given leptin’s dual role in metabolism and immunity, it is plausible that disruptions in leptin signaling—such as those observed in metabolic syndrome and obesity—contribute to prolonged inflammation and delayed fibrosis resolution in FS [22,23]. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.